Search research articles
Contact Us
Filters
Showing results (241-250 of 263) with videos related to
Page
of 27
Sort By:
Stem Cells and Development
|
February 13, 2015
Stem cell-derived systems in toxicology assessment
Laura Suter-Dick, Paula M Alves, Bas J Blaauboer, et al.
Archives of Toxicology
|
November 15, 2018
Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury
Ian M Copple, Wouter den Hollander, Giulia Callegaro, et al.
NPJ Genomic Medicine
|
January 18, 2026
Pharmacokinetic recall study of Estonian Biobank participants with novel genetic variants in CYP2C19 and CYP2D6
Kristi Krebs, Laura Birgit Luitva, Anette Caroline Kõre, et al.
Pharmacogenomics
|
September 25, 2015
Systems medicine, personalized health and therapy
Gérard Siest, Charles Auffray, Naoyuki Taniguchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 16, 2003
Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems
Jarmo S Salonen, Leena Nyman, Alan R Boobis, et al.
Pharmacogenomics
|
October 8, 2019
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation
Csilla Sipeky, Adrián Llerena, Vangelis G Manolopoulos, et al.
BMC Genomics
|
October 6, 2014
Genetic and epigenetic regulation of gene expression in fetal and adult human livers
Marc Jan Bonder, Silva Kasela, Mart Kals, et al.
Free Radical Biology & Medicine
|
December 3, 2014
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju, Ian M Copple, Holly K Bryan, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 20, 2011
CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP
Patricia Huezo-Diaz, Nader Perroud, Edgar P Spencer, et al.
Nature Communications
|
February 6, 2025
The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model
Jan Dusek, Ivana Mejdrová, Klára Dohnalová, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 263) with videos related to
Sort By:
Page
of 27
Stem Cells and Development
|
February 13, 2015
Stem cell-derived systems in toxicology assessment
Laura Suter-Dick, Paula M Alves, Bas J Blaauboer, et al.
Archives of Toxicology
|
November 15, 2018
Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury
Ian M Copple, Wouter den Hollander, Giulia Callegaro, et al.
NPJ Genomic Medicine
|
January 18, 2026
Pharmacokinetic recall study of Estonian Biobank participants with novel genetic variants in CYP2C19 and CYP2D6
Kristi Krebs, Laura Birgit Luitva, Anette Caroline Kõre, et al.
Pharmacogenomics
|
September 25, 2015
Systems medicine, personalized health and therapy
Gérard Siest, Charles Auffray, Naoyuki Taniguchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 16, 2003
Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems
Jarmo S Salonen, Leena Nyman, Alan R Boobis, et al.
Pharmacogenomics
|
October 8, 2019
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation
Csilla Sipeky, Adrián Llerena, Vangelis G Manolopoulos, et al.
BMC Genomics
|
October 6, 2014
Genetic and epigenetic regulation of gene expression in fetal and adult human livers
Marc Jan Bonder, Silva Kasela, Mart Kals, et al.
Free Radical Biology & Medicine
|
December 3, 2014
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju, Ian M Copple, Holly K Bryan, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 20, 2011
CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP
Patricia Huezo-Diaz, Nader Perroud, Edgar P Spencer, et al.
Nature Communications
|
February 6, 2025
The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model
Jan Dusek, Ivana Mejdrová, Klára Dohnalová, et al.
Page
of 27